Literature DB >> 8880139

Adherence of Mycoplasma pneumoniae to human alveolar macrophages.

A Athamna1, M R Kramer, I Kahane.   

Abstract

The human pathogen Mycoplasma pneumoniac causes primary atypical-cold agglutinin-positive pneumonia. Since alveolar macrophages internalize mycoplasma as part of their immune defense, we studied characteristics of the human macrophage receptor for opsonized and nonopsonized M. pneumoniae. The glass-adhering subpopulation of M. pneumoniae attached more than the non-adherent subpopulation. The attachment was dose-dependent and enhanced by opsonization in the presence of human serum. It is inhibited by sulfated compounds such as dextran-sulfate and polyanetholsulfonic acid, but not by dextran or several monosaccharides, suggesting that sulfated glycolipids on the macrophage surface may act as receptors for M. pneumoniae binding. In addition, sialylated compounds, such as fetuin and alpha 1-acid glycoprotein, were found to be potent inhibitors of the attachment, also indicating the role of sialic acid residue in recognition and attachment of M. pneumoniae to human alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880139     DOI: 10.1111/j.1574-695X.1996.tb00064.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  Lactation stage-related expression of sialylated and fucosylated glycotopes of human milk α-1-acid glycoprotein.

Authors:  Magdalena Orczyk-Pawiłowicz; Lidia Hirnle; Marta Berghausen-Mazur; Iwona M Kątnik-Prastowska
Journal:  Breastfeed Med       Date:  2014-06-03       Impact factor: 1.817

2.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

3.  Fucoxanthin, a Marine Carotenoid, Suppresses Mycoplasma pneumoniae-Triggered Inflammatory Cytokine Production and Promotes Bacterial Clearance in a Murine Model.

Authors:  Hongbo Wu; Shu Li; Linlin Wang; Jun Liang; Lei Yan; Jianjiang Dong
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-21       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.